Calendar

Events that a source expects, grouped by the month, quarter or half-year the source names, with who expected each and when they said so.

Upcoming as of , the date this release was built (the newest input commit date), not today's date. An expected date is a statement by the source, not a result, and it can move. Dated events are on the timeline.

8,817 of these dates come from registry records: the start, primary completion or completion that a registry expects of a trial. A program assembled them, and a registry often leaves a date unchanged after it has passed. The calendar file lists the dates of written pages only.

Add to your calendar (calendar.ics)

The calendar file has one all-day event for each upcoming item. Where a source gives only a month, a quarter, a half-year or a year, the event sits on the first day of that period and its title says "expected sometime in" the period.

Upcoming

September 2029 50

  1. Study completion OCT-Guided Stent Optimization for Short-Duration Dual Antiplatelet Therapy in Stable Angina Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07198529

  2. Primary completion OCT-Guided Stent Optimization for Short-Duration Dual Antiplatelet Therapy in Stable Angina Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07198529

  3. Study completion Normal Saline Infusion After Intravenous Thrombolysis in Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07497542

  4. Primary completion Safety and Efficacy of Low-dose Anticoagulation With Argatroban and Enoxaparin on ECMO Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07499037

  5. Study completion Advancing Clinical Heart Failure Outcomes Leveraging Defibrillation Lead Implant System for Left Bundle Branch Area Pacing Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07526896

  6. Primary completion Role of Neuroinflammation and Blood-Brain Barrier Breakdown in Intracerebral Hemorrhage. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07583147

  7. Study completion A Study of Metformin to Improve Cardiac Function After LVAD Implantation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07666698

  8. Primary completion Tricuspid Regurgitation Treatment With LAPLACE Transcatheter Tricuspid Valve Replacement System Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07687485

  9. Study completion Early Intensive Lipid-Lowering With Inclisiran for Plaque Stabilization in Acute Coronary Syndrome Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07799779

  10. Primary completion Early Intensive Lipid-Lowering With Inclisiran for Plaque Stabilization in Acute Coronary Syndrome Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07799779

  11. Study completion Efficacy and Safety of an LVEF-Guided Mavacamten Dose Up-Titration Strategy in Chinese Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07807384

  12. Primary completion Efficacy and Safety of an LVEF-Guided Mavacamten Dose Up-Titration Strategy in Chinese Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07807384

  13. Study completion A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07761117

  14. Primary completion A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07761117

  15. Primary completion ULTRAsound-assisted Catheter-guided Thrombolysis for Intermediate-high Risk Patients With PE Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07452991

  16. Primary completion Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07626411

  17. Primary completion Safety and Performance of the Affera SpherePVI™ Multi-Ablation System to Treat Paroxysmal Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05115214

  18. Primary completion Safety and Performance of the SpherePVI™ Catheter to Treat Paroxysmal Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05144503

  19. Study completion Neuroprotection in Acute Cerebral Ischemia II Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07552818

  20. Study completion LAAO Versus NOAC in Patients with AF and PCI Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05353140

  21. Study completion Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02915198

  22. Primary completion Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02915198

  23. Study completion The RESET System Pivotal Clinical Trial (Protocol Revision K) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04101669

  24. Study completion Pediatric Prehospital Airway Resuscitation Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06364280

  25. Study completion A Registry-based Randomized Controlled Trial in Type 2 Diabetes With Cardiovascular Risk Factors (REMATCH) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06627322

  26. Primary completion A Registry-based Randomized Controlled Trial in Type 2 Diabetes With Cardiovascular Risk Factors (REMATCH) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06627322

  27. Primary completion A Prospective Trial of Enavogliflozin to Evaluate Cardio-renal Outcome in Type 2 Diabetes Mellitus Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06642623

  28. Study completion STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients Without an Indication for Oral Anticoagulant Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07007143

  29. Primary completion Eptifibatide for Extended Window Ischemic Stroke After Thrombolysis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07347626

  30. Study completion Zastaprazan for the prEvention of Upper GI Bleeding in Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07730840

  31. Primary completion Zastaprazan for the prEvention of Upper GI Bleeding in Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07730840

  32. Primary completion PATHS-T2D: A Recall-by-Genotype Study of Physiologic and Pharmacologic Responses Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07739537

  33. Study completion Optimal Anti-Thrombotic Management Following Percutaneous Left Atrial Appendage Occlusion Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07840365

  34. Study completion Comparison of Fractional FLOW Reserve Outcomes With Drug-Coated Balloon-Based Versus Drug-Eluting Stent-Only Percutaneous Coronary Intervention Strategies Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07852689

October 2029 40

  1. Primary completion Assessing the Safety and Efficacy of the LAmbre™ Plus Device Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06465706

  2. Study completion Response to Exercise and Nitric Oxide in PAD Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06657976

  3. Study completion NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04471909

  4. Study completion Deferoxamine In the Treatment of Aneurysmal Subarachnoid Hemorrhage (aSAH) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04566991

  5. Primary completion Deferoxamine In the Treatment of Aneurysmal Subarachnoid Hemorrhage (aSAH) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04566991

  6. Primary completion Evaluation of the GORE® Ascending Stent Graft Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05800743

  7. Study completion Secondary Prevention of VTE in Patients With Cancer and Catheter-Related Upper Extremity Deep Vein Thrombosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06603870

  8. Primary completion Secondary Prevention of VTE in Patients With Cancer and Catheter-Related Upper Extremity Deep Vein Thrombosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06603870

  9. Study completion Safety and Efficacy of Very Short DAPT in Older Patients Undergoing PCI Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07164859

  10. Primary completion Safety and Efficacy of Very Short DAPT in Older Patients Undergoing PCI Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07164859

  11. Study completion Reversal to Normoglycemia by Treating Prediabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07392151

  12. Primary completion Reversal to Normoglycemia by Treating Prediabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07392151

  13. Study completion SWITCH: Apixaban vs Vitamin K in HM3 Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07471139

  14. Study completion A Study to Determine if BHV-1400 is Effective and Safe in Adults With IgA Nephropathy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07642050

  15. Study completion Platelet Aggregation Function-Guided De-Escalation Antiplatelet Therapy in Patients With Acute Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07644234

  16. Study completion DAN-RELEASE - Reconsidering Long-Term Aspirin in the Elderly Patients With Stable Ischemic Heart Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07795398

  17. Primary completion DAN-RELEASE - Reconsidering Long-Term Aspirin in the Elderly Patients With Stable Ischemic Heart Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07795398

  18. Primary completion Implementing Improved Blood Pressure Measurement in General Practice: A Multisite Implementation Trial Using Automated Office Blood Pressure (AOBP) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07822022

  19. Primary completion A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07881458

  20. Study completion Tolerability and Safety of Nano-Tocotrienols Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07888426

  21. Primary completion Tolerability and Safety of Nano-Tocotrienols Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07888426

  22. Study completion A Comparison of Beta-blockers and Calcium Channel Blockers in Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07904507

  23. Primary completion A Comparison of Beta-blockers and Calcium Channel Blockers in Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07904507

  24. Study completion Abatacept in Immune Checkpoint Inhibitor Myocarditis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05335928

  25. Study completion COSIMA: COronary SInus Reducer for the Treatment of Refractory Microvascular Angina Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04606459

  26. Study completion A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07000357

  27. Primary completion A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07000357

  28. Study completion Implementation Study on Hospital-to-home Advanced Rehabilitation Technologies (ART) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07904624

  29. Primary completion Implementation Study on Hospital-to-home Advanced Rehabilitation Technologies (ART) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07904624

  30. Study completion A Prospective Multicenter Pivotal Study to Evaluate Safety and Effectiveness of Venus-Neo Surgical Aortic Valve Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05941455

  31. Study completion Percutaneous Embolectomy, Low Dose Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism (STRATIFY II) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06453876

  32. Study completion The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic Cancer Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06861088

  33. Primary completion Optimizing Reperfusion to Improve Outcomes and Neurologic Function Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06990867

  34. Study completion Sodium-Glucose Cotransporter-2 Inhibitor for Patients With Acute Cardiorenal Syndrome Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07273838

  35. Study completion Investigating Central Contributions to Fatigue Using Non-invasive Brain Stimulation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07613970

  36. Primary completion Investigating Central Contributions to Fatigue Using Non-invasive Brain Stimulation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07613970

  37. Primary completion Vericiguat for the Inhibition of Calcific Aortic Valve Stenosis Progression Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07715279

  38. Primary completion A Study to Predict Atrial Fibrillation (AF) Burden in Participants With PAF and PsAF Treated With the VARIPULSE™ PFA Catheter Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07788989

November 2029 25

  1. Primary completion Medical Management With Endovascular Thrombectomy Versus Medical Management Alone in Patients Presenting Beyond 24 Hours of Last Known Well Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07115940

  2. Study completion Low-VOLTage Area-Guided Catheter Ablation and SVC Isolation for Persistent Atrial Fibrillation Using a Balloon-in-Basket Pulsed Field Ablation Catheter Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07587541

  3. Primary completion Low-VOLTage Area-Guided Catheter Ablation and SVC Isolation for Persistent Atrial Fibrillation Using a Balloon-in-Basket Pulsed Field Ablation Catheter Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07587541

  4. Primary completion Study Evaluating the Metabolic Effects of pulsENDO Therapy in Adults With Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07768631

  5. Study completion Comparing PFO Outcomes of the Occlutech Flex II PFO Occluder to Standard of Care PFO Occlusion Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05069558

  6. Study completion XVIVO Heart Perfusion System (XHPS) With Supplemented XVIVO Heart Solution (SXHS) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05881278

  7. Study completion A Study to Investigate Efficacy and Safety of a TCA108 in Participants ≥18 Years With Uncontrolled Hypertension Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07030101

  8. Study completion Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07069738

  9. Primary completion Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07069738

  10. Study completion A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07881458

  11. Primary completion A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07900633

  12. Study completion A Study of Bimagrumab in Participants With HFpEF Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07920887

  13. Primary completion Fibroblast Growth Factor-1 (FGF-1) for the Treatment of Coronary Heart Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT00117936

  14. Primary completion Individualized Genotype-guided Antiplatelet Therapy in Patients With Acute Coronary Syndrome Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07939516

  15. Study completion Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07318610

  16. Study completion Gapless ECG-Monitoring for Stroke Prevention by Atrial Fibrillation Detection (GEMS-PAF-randomized Trial) - A Multi-centre, Randomized Controlled Outcome Trial. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07941167

  17. Primary completion Gapless ECG-Monitoring for Stroke Prevention by Atrial Fibrillation Detection (GEMS-PAF-randomized Trial) - A Multi-centre, Randomized Controlled Outcome Trial. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07941167

  18. Study completion Safety and Efficacy of the GeminiOne Transcatheter Valve Edge-to-Edge Repair System in Patients With Moderate-severe or Severe Degenerative Mitral Regurgitation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05655897

  19. Primary completion Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef Outcomes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06008756

  20. Study completion SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05198674

  21. Study completion SUMMIT RISE Study of Acute Ischemic Stroke Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07436156

  22. Study completion A Phase 3 Study of Extended-release Tacrolimus in Subjects With Pulmonary Arterial Hypertension and Functional Limitations Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07612657

  23. Study completion Vericiguat for the Inhibition of Calcific Aortic Valve Stenosis Progression Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07715279

  24. Primary completion Percutaneous Stellate Ganglion Block as First Line Treatment in Patients With Electrical Storm: the STAR 2 Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07841080

Overdue

The expected date has passed and no published record says the event happened. This does not mean it failed or was delayed: the atlas may not have checked the source since. Oldest first.

  1. Study start Evaluation of Safety and Effectiveness of the EMBLOK EPS Compared With No Cerebral Embolic Protection During TAVR Registry record

    Expected 2025-10-21; that period ended on 2025-10-21.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07129421

  2. Study start The Safety and Efficacy of New-Generation BRS vs. DCB for De Novo Large Coronary Artery Lesions: A Prospective RCT Registry record

    Expected 2025-10-23; that period ended on 2025-10-23.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07162792

  3. Primary completion Effect of Tofogliflozin on UACR Compared to Metformin Hydrochloride in Diabetic Kidney Disease (TRUTH-DKD) Registry record

    Expected 2025-10-30; that period ended on 2025-10-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05469659

  4. Study completion De-escalating Antiplatelet Therapy to Assess Platelet Reactivity and Outcomes in High Bleeding Risk Patients With Recent ACS Registry record

    Expected 2025-10-30; that period ended on 2025-10-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05903976

  5. Study completion Normobaric Hyperoxia Combined With Intravenous Thrombolysis for Acute Ischemic Stroke:Longterm Outcome (OPENS-3L) Registry record

    Expected 2025-10-30; that period ended on 2025-10-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05965193

  6. Primary completion Registration Trial of the Intracranial Visualized Stent for the Wide-necked Intracranial Aneurysms:REBRIDGE Registry record

    Expected 2025-10-30; that period ended on 2025-10-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06189950

  7. Study start Interleukin-6 Receptor Inhibition for Symptomatic Intracranial Atherosclerosis Registry record

    Expected 2025-10-30; that period ended on 2025-10-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06447701

  8. Study completion The Androtriol Injection for the Treatment of Acute Ischemic Stroke Registry record

    Expected 2025-10-30; that period ended on 2025-10-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06679322

  9. Study completion Phase II Study of PG-102(MG12) Compared With Placebo in Obesity and Type 2 Diabetes Registry record

    Expected 2025-10-30; that period ended on 2025-10-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06712615

  10. Primary completion Phase II Study of PG-102(MG12) Compared With Placebo in Obesity and Type 2 Diabetes Registry record

    Expected 2025-10-30; that period ended on 2025-10-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06712615

  11. Study start Clinical Prospective ranDomized Trial to Evaluate the Non-inferiority of Left Bundle Branch Area Pacing Vs Cardiac ResynchronIzatioN Therapy With ECG guIded AV Optimization Registry record

    Expected 2025-10-30; that period ended on 2025-10-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07107048

  12. Study completion Subclinical AtrIal FibrilLation and StrokE PreveNtion Trial Registry record

    Expected 2025-10-31; that period ended on 2025-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02004509

  13. Primary completion Subclinical AtrIal FibrilLation and StrokE PreveNtion Trial Registry record

    Expected 2025-10-31; that period ended on 2025-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02004509

  14. Study completion The Recovery in Stroke Using PAP Study Registry record

    Expected 2025-10; that period ended on 2025-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04130503

  15. Primary completion The Recovery in Stroke Using PAP Study Registry record

    Expected 2025-10; that period ended on 2025-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04130503

  16. Primary completion Huaiqihuang Granule in the Treatment of Primary Glomerulonephritis of Stage CKD3 Registry record

    Expected 2025-10-31; that period ended on 2025-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04263922

  17. Primary completion NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness Registry record

    Expected 2025-10; that period ended on 2025-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04471909

  18. Study completion Image Supported Lead Placement in CRT Registry record

    Expected 2025-10; that period ended on 2025-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05053568

  19. Primary completion The ELG Analysis of Glucose a Correlational to Blood Glucose Assay Registry record

    Expected 2025-10; that period ended on 2025-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05055804

  20. Primary completion Biomarker-Guided Optimization of Transcutaneous Vagal Stimulation for Atrial (BiG tVNS-AF) Registry record

    Expected 2025-10-31; that period ended on 2025-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05172765

  21. Primary completion MAGNAM Trial, Magnesium Versus Amiodarone in Atrial Fibrillation in Critical Care Registry record

    Expected 2025-10-31; that period ended on 2025-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05287191

  22. Study completion EMPAGUM: Effects of Empagliflozin on Gut Microbiota in Heart Failure With a Preserved Ejection Fraction Registry record

    Expected 2025-10; that period ended on 2025-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05584319

  23. Study completion Empagliflozin on the Function of Left Atrium in Heart Failure With Mildly Reduced or Preserved Ejection Fraction Registry record

    Expected 2025-10; that period ended on 2025-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05600387

  24. Study completion Beneficial Effects of Vitamin D Combined With Oral Iron Supplementation in Patients With Chronic Heart Failure and Iron Deficiency Registry record

    Expected 2025-10-31; that period ended on 2025-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05702970

  25. Primary completion Improving Stroke Care in North-Norway Through Artificial Intelligence Registry record

    Expected 2025-10-31; that period ended on 2025-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05903898

  26. Primary completion A Prospective Multicenter Pivotal Study to Evaluate Safety and Effectiveness of Venus-Neo Surgical Aortic Valve Registry record

    Expected 2025-10-31; that period ended on 2025-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05941455

  27. Study completion Assessment of Efficacy and Safety of Amicomed®, for the Management of Essential Hypertension Registry record

    Expected 2025-10-31; that period ended on 2025-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06091176

  28. Study completion A Trial to Investigate the Efficacy and Safety of NW Low-Glu® in Patients With Type II Diabetes Mellitus Registry record

    Expected 2025-10; that period ended on 2025-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06140485

  29. Primary completion Tirofiban for Patients With intraCranial Artery Stenosis and High-risk Acute Non-disabling Cerebrovascular Events(CHANCE-4) Registry record

    Expected 2025-10; that period ended on 2025-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06319846

  30. Primary completion Real World Evaluation of Lifelight®: A Contactless Vital Signs Monitor for Self-monitoring Blood Pressure and Its Comparison to Standard of Care Registry record

    Expected 2025-10-31; that period ended on 2025-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06325384

  31. Primary completion Bioabsorbable/Nufairy Coil Application Trial in China Registry record

    Expected 2025-10-31; that period ended on 2025-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06466564

  32. Primary completion Efficacy and Safety of the Liquid Embolic System (Tonbridge) for Endovascular Treatment of Cerebrovascular Malformations Registry record

    Expected 2025-10; that period ended on 2025-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06479343

  33. Primary completion A Trial Investigating the Efficacy and Safety of Insulin Degludec/Liraglutide Injection in Subjects With Type 2 Diabetes Registry record

    Expected 2025-10; that period ended on 2025-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06559722

  34. Primary completion Clinical Trial of Ventiflow LP Supporting High-risk Percutaneous Coronary Intervention(PCI) Registry record

    Expected 2025-10; that period ended on 2025-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06754839

  35. Study completion CAP-TEER: CerebrAl Protection During Transcatheter Edge-to-edge Repair Registry record

    Expected 2025-10-31; that period ended on 2025-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06814210

  36. Study start Use of New Drug QRX-3 for Prevention and Treatment of Chronic Kidney Disease Progression Registry record

    Expected 2025-10; that period ended on 2025-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06866236

  37. Study completion The Effects of Hydroxychloroquine in Patients with Inflammatory Cardiomyopathy Registry record

    Expected 2025-11-01; that period ended on 2025-11-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05961202

  38. Primary completion Continuous Steroid Monitoring in Interstitial Fluid With Wearable and Nanoparticle-enhanced Biosensors for Improved Management of Adrenal Disorders Registry record

    Expected 2025-11-01; that period ended on 2025-11-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06980753

  39. Study start CGM Use in Non-insulin Patients With DM2 Registry record

    Expected 2025-11-01; that period ended on 2025-11-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07128342

  40. Study start Tenecteplase vs Medical Management in 4.5-24h LVO no Access to EVT Registry record

    Expected 2025-11-01; that period ended on 2025-11-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07168278

  41. Study start Empagliflozin Versus Statins in Non-Alcoholic Fatty Liver Disease Registry record

    Expected 2025-11-01; that period ended on 2025-11-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07180745

  42. Study start RK-4 Intracalvariosseous Injection in Treatment of Acute Large Hemispheric Infarction Registry record

    Expected 2025-11-01; that period ended on 2025-11-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07203521

  43. Primary completion Treatment of PAF With the Synaptic System Registry record

    Expected 2025-11-05; that period ended on 2025-11-05.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05905835

  44. Study start DCB vs. DES in Young STEMI Patients: The DCB-STEMI Trial Registry record

    Expected 2025-11-05; that period ended on 2025-11-05.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07229248

  45. Primary completion Comparative Efficacy of Rivaroxaban and Enoxaparin in Post-Laparotomy DVT Prevention Registry record

    Expected 2025-11-10; that period ended on 2025-11-10.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07243080

  46. Primary completion Phimume® Percutaneous Left Ventricular Assist System Study Registry record

    Expected 2025-11-14; that period ended on 2025-11-14.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06639321

  47. Study completion Comparative Efficacy of Rivaroxaban and Enoxaparin in Post-Laparotomy DVT Prevention Registry record

    Expected 2025-11-15; that period ended on 2025-11-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07243080

  48. Study completion Mobile Application for Self-Management of Type 2 Diabetes Mellitus Registry record

    Expected 2025-11-22; that period ended on 2025-11-22.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06176703

  49. Primary completion VIRTUOSE : Efficiency of Sildenafil on the Absolute Claudication Distance of Peripheral Arterial Disease Patients With Intermittent Claudication. Registry record

    Expected 2025-11-24; that period ended on 2025-11-24.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03686306

  50. Primary completion Safety and Efficacy of the GeminiOne Transcatheter Valve Edge-to-Edge Repair System in Patients With Moderate-severe or Severe Degenerative Mitral Regurgitation Registry record

    Expected 2025-11-24; that period ended on 2025-11-24.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05655897

  51. Study completion Non-elastic Compression Garment Therapy Versus Control for Deep Vein Thrombosis Registry record

    Expected 2025-11-30; that period ended on 2025-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03368313

  52. Study completion Effectiveness and Safety of the RIGHTEST Continuous Glucose Monitoring System for Blood Glucose Management in Persons With Diabetes Mellitus Registry record

    Expected 2025-11; that period ended on 2025-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04838392

  53. Study completion The ELG Analysis of Glucose a Correlational to Blood Glucose Assay Registry record

    Expected 2025-11; that period ended on 2025-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05055804

  54. Study completion Pulmonary REsistance Modification Under Treatment With Sacubitril/valsartaN in paTients With Heart Failure With Reduced Ejection Fraction Registry record

    Expected 2025-11; that period ended on 2025-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05487261

  55. Study completion A Post Marketing Surveillance to Evaluate the Safety of Desidustat for the Treatment of Anemia in Subjects With Chronic Kidney Disease (CKD).(Real World Evidence Study) Registry record

    Expected 2025-11-30; that period ended on 2025-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05515367

  56. Study completion Effect of Prolonged Use of Dronedarone on Recurrence in Patients With Non-paroxysmal Atrial Fibrillation After Radiofrequency Ablation Registry record

    Expected 2025-11; that period ended on 2025-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05655468

  57. Primary completion Vagal Nerve Stimulation for the Treatment of Persistent AF Registry record

    Expected 2025-11-30; that period ended on 2025-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05833373

  58. Primary completion Innovative Approaches for Personalised Cardiovascular Prevention Registry record

    Expected 2025-11; that period ended on 2025-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05883878

  59. Primary completion Clinical Study on the Noninvasive Lung Fluid Monitoring System in Guiding the Treatment of Heart Failure Registry record

    Expected 2025-11; that period ended on 2025-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06102031

  60. Study completion Natriuresis-Guided Diuretic Therapy in Patients With Acute Heart Failure With Reduced Ejection Fraction and Chronic Kidney Disease Registry record

    Expected 2025-11; that period ended on 2025-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06203236

  61. Primary completion Ticagrelor Versus Cilostazol in Ischemic Stroke Registry record

    Expected 2025-11-30; that period ended on 2025-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06561867

  62. Primary completion Vaccination Against Influenza Pre-discharge in Heart Failure Registry record

    Expected 2025-11-30; that period ended on 2025-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06725927

  63. Study completion Apixaban Prophylaxis for Prevention of Left Ventricular Thrombus Following Anterior Myocardial Infarction Registry record

    Expected 2025-11-30; that period ended on 2025-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06742567

  64. Primary completion Apixaban Prophylaxis for Prevention of Left Ventricular Thrombus Following Anterior Myocardial Infarction Registry record

    Expected 2025-11-30; that period ended on 2025-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06742567

  65. Primary completion WeArable teChnology daTa driVen digitAl healTh cOachINg (ACTIVATION)- A Mixed-methods Study Registry record

    Expected 2025-11; that period ended on 2025-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06752772

  66. Primary completion Aleeto in Acute ISchemic Stroke:A RandomISed Controlled Clinical Trial Registry record

    Expected 2025-11-30; that period ended on 2025-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06759753

  67. Study start Ganagliflozin on the Progression of Kidney Disease in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease Registry record

    Expected 2025-11-30; that period ended on 2025-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07116928

  68. Study start Sacubitril/Allisartan for Hypertensive Patients With Overweight or Obesity Registry record

    Expected 2025-11; that period ended on 2025-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07241338

  69. Study start Evaluating Functional Outcomes of 3D-Printed Splints in Post-Stroke Upper Limb Recovery Registry record

    Expected 2025-11; that period ended on 2025-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07243314

  70. Study completion HELIOS China Registry: Evaluation of the HELIOS Stent in a Real-World Patient Population Registry record

    Expected 2025-12-01; that period ended on 2025-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03916432

  71. Study completion Short Arm Human Centrifuge Therapeutic Training and Rehabilitation (GRACER1) Registry record

    Expected 2025-12-01; that period ended on 2025-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04369976

  72. Study completion TROPHY PAH Pivotal Study - TReatment of Pulmonary HYpertension for PAH Pivotal Study Registry record

    Expected 2025-12-01; that period ended on 2025-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04570228

  73. Study completion A Cognitive Behavioral Digital Therapeutic InterventiON for Glycemic Control in Type 2 Diabetes Mellitus Registry record

    Expected 2025-12-01; that period ended on 2025-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05302050

  74. Primary completion A Cognitive Behavioral Digital Therapeutic InterventiON for Glycemic Control in Type 2 Diabetes Mellitus Registry record

    Expected 2025-12-01; that period ended on 2025-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05302050

  75. Study completion Left Ventricular Unloading to Improve Outcome in Cardiogenic Shock Patients on VA-ECMO Registry record

    Expected 2025-12-01; that period ended on 2025-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05577195

  76. Primary completion High-Dose Atorvastatin for Vascular Wall Protection in Thrombectomy Patients Registry record

    Expected 2025-12-01; that period ended on 2025-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05912686

  77. Study completion Evaluation of the Safety and Efficacy of SGLT2 Inhibitors in Pre-diabetic Patients Registry record

    Expected 2025-12-01; that period ended on 2025-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05914857

  78. Study completion taVNS Paired With Motor Training for Upper-extremity Rehabilitation in Stroke Patients Registry record

    Expected 2025-12-01; that period ended on 2025-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05943431

  79. Study completion Effect of Spironolactone in the Prevention of Anthracycline-induced Cardiotoxicity (SPIROTOX) Registry record

    Expected 2025-12-01; that period ended on 2025-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06005259

  80. Primary completion Pulsed-field Ablation for Patients With Asymptomatic Non-paroxysmal Atrial Fibrillation Registry record

    Expected 2025-12-01; that period ended on 2025-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06166524

  81. Primary completion Optimal Medical Treatment of Difficult-to-treat Hypertension Registry record

    Expected 2025-12-01; that period ended on 2025-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06275763

  82. Study completion Effects of First-Line Oral Hypoglycemics in Bone Markers of Treatment Naïve Saudi Adults With Type 2 Diabetes Registry record

    Expected 2025-12-01; that period ended on 2025-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06439758

  83. Primary completion Ticagrelore Alone Post PCI Registry record

    Expected 2025-12-01; that period ended on 2025-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06509893

  84. Primary completion Emergency Stroke Unit for Acute Cerebrovascular Events ( ESU-ACE-D ) Registry record

    Expected 2025-12-01; that period ended on 2025-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06522282

  85. Primary completion PREVENTION OF WORSENING RENAL FUNCTION OF INTRAVENUS ALBUMIN IN HEART FAILURE PATIENTS Registry record

    Expected 2025-12-01; that period ended on 2025-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06630923

  86. Study completion Continuous Steroid Monitoring in Interstitial Fluid With Wearable and Nanoparticle-enhanced Biosensors for Improved Management of Adrenal Disorders Registry record

    Expected 2025-12-01; that period ended on 2025-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06980753

  87. Study start Intravenous Tirofiban After Delayed Thrombolysis in Stroke Registry record

    Expected 2025-12-01; that period ended on 2025-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07111806

  88. Study start Development and Validation of a Comprehensive Management Service Package for Older Adults With Multimorbidity Registry record

    Expected 2025-12-01; that period ended on 2025-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07151430

  89. Study start Butylphthalide for Long-term Efficacy in Minor Stroke Study Registry record

    Expected 2025-12-01; that period ended on 2025-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07230587

  90. Study start Evaluating the Safety and Effectiveness of a Vascular Interventional Robotic System in Assisting With Percutaneous Coronary Intervention Procedures: A Prospective, Multicenter, Randomized Controlled Clinical Trial Registry record

    Expected 2025-12-01; that period ended on 2025-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07233317

  91. Study start Isosorbide Mononitrate and Butylphthalide to Reduce the Risk of Disability in Patients With Acute Lacunar Stroke (IMPACT) Registry record

    Expected 2025-12-01; that period ended on 2025-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07252544

  92. Study start Acetyl-leucine in Post-stroke Ataxia Registry record

    Expected 2025-12-01; that period ended on 2025-12-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07275749

  93. Study completion Treatment of PAF With the Synaptic System Registry record

    Expected 2025-12-05; that period ended on 2025-12-05.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05905835

  94. Primary completion Combinating Fingolimod With Alteplase Bridging With Thrombectomy in Acute Ischemic Stroke Registry record

    Expected 2025-12-15; that period ended on 2025-12-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04675762

  95. Study completion Olive Leaf Extracts in the Control of Diabet Registry record

    Expected 2025-12-15; that period ended on 2025-12-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05605704

  96. Study start A Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus. Registry record

    Expected 2025-12-15; that period ended on 2025-12-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06731075

  97. Primary completion Evaluate the Efficacy and Safety of SPC1001 Low in Patients With Essential Hypertension Registry record

    Expected 2025-12-15; that period ended on 2025-12-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07064525